KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eli Lilly (LLY) Non-Current Deferred Tax Liability (2018 - 2022)

Eli Lilly filings provide 11 years of Non-Current Deferred Tax Liability readings, the most recent being $4.6 billion for Q4 2022.

  • On a quarterly basis, Non-Current Deferred Tax Liability rose 164.12% to $4.6 billion in Q4 2022 year-over-year; TTM through Dec 2022 was $4.6 billion, a 164.12% increase, with the full-year FY2022 number at $4.6 billion, up 164.12% from a year prior.
  • Non-Current Deferred Tax Liability hit $4.6 billion in Q4 2022 for Eli Lilly, up from $171.9 million in the prior quarter.
  • In the past five years, Non-Current Deferred Tax Liability ranged from a high of $5.1 billion in Q4 2020 to a low of $171.9 million in Q3 2022.
  • Median Non-Current Deferred Tax Liability over the past 5 years was $2.2 billion (2020), compared with a mean of $2.4 billion.
  • The widest YoY moves for Non-Current Deferred Tax Liability: up 164.12% in 2022, down 89.47% in 2022.
  • Eli Lilly's Non-Current Deferred Tax Liability stood at $3.0 billion in 2018, then surged by 51.61% to $4.6 billion in 2019, then rose by 10.13% to $5.1 billion in 2020, then plummeted by 65.81% to $1.7 billion in 2021, then soared by 164.12% to $4.6 billion in 2022.
  • The last three reported values for Non-Current Deferred Tax Liability were $4.6 billion (Q4 2022), $171.9 million (Q3 2022), and $862.5 million (Q2 2022) per Business Quant data.